Cargando…

Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF

In age-related macular degeneration (AMD) or diabetic retinopathy (DR), hypoxia and inflammatory processes lead to an upregulation of the vascular endothelial growth factor (VEGF) expression and thereby to pathological neovascularisation with incorrectly formed vessels prone to damage, thus increasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stumpf, Constanze, Wimmer, Tobias, Lorenz, Birgit, Stieger, Knut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098639/
https://www.ncbi.nlm.nih.gov/pubmed/32214330
http://dx.doi.org/10.1371/journal.pone.0230344
_version_ 1783511218385846272
author Stumpf, Constanze
Wimmer, Tobias
Lorenz, Birgit
Stieger, Knut
author_facet Stumpf, Constanze
Wimmer, Tobias
Lorenz, Birgit
Stieger, Knut
author_sort Stumpf, Constanze
collection PubMed
description In age-related macular degeneration (AMD) or diabetic retinopathy (DR), hypoxia and inflammatory processes lead to an upregulation of the vascular endothelial growth factor (VEGF) expression and thereby to pathological neovascularisation with incorrectly formed vessels prone to damage, thus increasing the vascular permeability and the risk of bleeding and oedema in the retina. State of the art treatment is the repeated intraocular injection of anti-VEGF molecules. For developing improved individualized treatment approaches, a minimally invasive, repeatable method for in vivo quantification of VEGF in the eye is necessary. Therefore, we designed single molecule eBRET2 VEGF biosensors by directly fusing a Renilla luciferase mutant (Rluc8) N-terminal and a green fluorescent protein (GFP2) C-terminal to a VEGF binding domain. In total, 10 different VEGF biosensors (Re01- Re10) were generated based on either single domains or full length of VEGF receptor 1 or 2 extracellular regions as VEGF binding domains. Full length expression of the biosensors in HEK293-T cells was verified via Western Blot employing an anti-Rluc8-IgG. Expression of alternative splice variants was eliminated through the deletion of the donor splice site by introduction of a silent point mutation. In all ten biosensors the energy transfer from the Rluc8 to the GFP2 occurs and generates a measurable eBRET2 ratio. Four biosensors show a relevant change of the BRET ratio (ΔBR) after VEGF binding. Furthermore, each biosensor shows a unique detection range for VEGF quantification and especially Re06 and Re07 have a high sensitivity in the range of in vivo VEGF concentrations in the eye, previously measured by invasive methods. In conclusion, we generated several eBRET2 biosensors that are suitable for VEGF quantification in vitro and could identify two eBRET2 biosensors, which may be suitable for non-invasive in vivo VEGF quantification with an implantable device.
format Online
Article
Text
id pubmed-7098639
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-70986392020-04-03 Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF Stumpf, Constanze Wimmer, Tobias Lorenz, Birgit Stieger, Knut PLoS One Research Article In age-related macular degeneration (AMD) or diabetic retinopathy (DR), hypoxia and inflammatory processes lead to an upregulation of the vascular endothelial growth factor (VEGF) expression and thereby to pathological neovascularisation with incorrectly formed vessels prone to damage, thus increasing the vascular permeability and the risk of bleeding and oedema in the retina. State of the art treatment is the repeated intraocular injection of anti-VEGF molecules. For developing improved individualized treatment approaches, a minimally invasive, repeatable method for in vivo quantification of VEGF in the eye is necessary. Therefore, we designed single molecule eBRET2 VEGF biosensors by directly fusing a Renilla luciferase mutant (Rluc8) N-terminal and a green fluorescent protein (GFP2) C-terminal to a VEGF binding domain. In total, 10 different VEGF biosensors (Re01- Re10) were generated based on either single domains or full length of VEGF receptor 1 or 2 extracellular regions as VEGF binding domains. Full length expression of the biosensors in HEK293-T cells was verified via Western Blot employing an anti-Rluc8-IgG. Expression of alternative splice variants was eliminated through the deletion of the donor splice site by introduction of a silent point mutation. In all ten biosensors the energy transfer from the Rluc8 to the GFP2 occurs and generates a measurable eBRET2 ratio. Four biosensors show a relevant change of the BRET ratio (ΔBR) after VEGF binding. Furthermore, each biosensor shows a unique detection range for VEGF quantification and especially Re06 and Re07 have a high sensitivity in the range of in vivo VEGF concentrations in the eye, previously measured by invasive methods. In conclusion, we generated several eBRET2 biosensors that are suitable for VEGF quantification in vitro and could identify two eBRET2 biosensors, which may be suitable for non-invasive in vivo VEGF quantification with an implantable device. Public Library of Science 2020-03-26 /pmc/articles/PMC7098639/ /pubmed/32214330 http://dx.doi.org/10.1371/journal.pone.0230344 Text en © 2020 Stumpf et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Stumpf, Constanze
Wimmer, Tobias
Lorenz, Birgit
Stieger, Knut
Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF
title Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF
title_full Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF
title_fullStr Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF
title_full_unstemmed Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF
title_short Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF
title_sort creation of different bioluminescence resonance energy transfer based biosensors with high affinity to vegf
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098639/
https://www.ncbi.nlm.nih.gov/pubmed/32214330
http://dx.doi.org/10.1371/journal.pone.0230344
work_keys_str_mv AT stumpfconstanze creationofdifferentbioluminescenceresonanceenergytransferbasedbiosensorswithhighaffinitytovegf
AT wimmertobias creationofdifferentbioluminescenceresonanceenergytransferbasedbiosensorswithhighaffinitytovegf
AT lorenzbirgit creationofdifferentbioluminescenceresonanceenergytransferbasedbiosensorswithhighaffinitytovegf
AT stiegerknut creationofdifferentbioluminescenceresonanceenergytransferbasedbiosensorswithhighaffinitytovegf